(Q33806643)
Statements
1 reference
Optimized viral dose and transient immunosuppression enable herpes simplex virus ICP0-null mutants To establish wild-type levels of latency in vivo (English)
1 reference
W P Halford
1 reference
P A Schaffer
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference